Targeting Isocitrate Lyase (ICL) For the Treatment of Talent Tuberculosis

Tuberculosis commonly termed as TB is a contagious infection majorly attacking the lungs of a human being. It also can spread to other vital parts of the body such as the brain as well as the spinal cord. Its core deadly causative agent is the Mycobacterium tuberculosis. From the statistics, it has been known to contribute to the mortality rate in the entire cosmos. For instance, in the 20th century, it was the leading killer disease in the United States. The technological advancements, as well as the inventions, have led to the emanation of antibiotics though its known to take a long time before it ultimately gets wiped off in the human body system. It is merely because it embodies has a long latency period [McHugh, T. D. 2013]. It may cocoons itself within the macrophages for even a span pan of years resulting in germination of a given syndrome called latent TB. The macrophages are the phagocytic tissue cells belonging to the immune system that may either be motile or stationary, and it is derived from a monocyte. Its function is destructing the foreign antigens and for instance bacterial ones.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Save 25%

Usually, the intimate surrounding of the macrophages lacks the eternal nutrients. The mycobacterium survives the hypoxic environment by simply catabolizing diverse sources of carbon. The sources may include the cholesterols as well as the fatty acids that are readily available in those macrophages (Acton, Q. A. 2012). The enzymes act as the key cornerstones contributing in both the methyl citrates as well as Mycobacterium glycosylate. In line to the methyl citrate phase, the enzymes usually catalyze the conversion of methylisocitrate which is commonly the central point of the propionate pathway of degradation to succinate and pyruvate. Propionate is generated through the oxidation of the cholesterol as well as the odd-chain fatty acids that the causative agent may utilize as the primary source of carbon. (Duca, G. 2012).

The ICL is an enzyme depending on magnesium and catalyzes the changeable lysis of a typical bond of the D-isocitrate to form succinate as well as the glyoxylate. The catalyst is thereby present in the mycobacteria excluding human beings. In the Mycobacterium tuberculosis there exist two isoforms of ICL namely ICL2 and ICL1, encoded by the genes icl1 as well as the ace A. It can be found in specific mycobacterial species which includes the Mycobacterium tuberculosis H37Rv being the most studied laboratory strains whereby the gene ace A gets split into two open frames known as the access and aceAb . It has not been vividly found whether the two genes encode the stable proteins or even whether the proteins that the genes encode possess possible ICL activities. The analysis indicates that despite both ICL1 and ICL2 allots around twenty-seven percent sequence identity; the ICL1 is a prokaryotic-like ICL isoform while ICL2 is a eukaryotic-like ICL isoform. Zelaya, (A. A., & Farnia, P. 2017). The most concentrated isoform of the Mycobacterium tuberculosis ICLs is ICL1 naturally because ICL2 was found to be unstable in the video. Therefore, ICL1 has a superior inclination to the D-isocitrate than ICL2 at the same time it is more so active than ICL2 in vitro. The enzyme ICL was proposed playing an essential role in the metabolism of fatty acids in Mycobacterium tuberculosis.

The Tricarboxylic acid cycle (TCA) also known as the Krebs cycle is the second stage of cellular respiration whereby living cells decomposes the molecules of the organic fuel in the presence of vital air known as oxygen to harness the energy they require fundamentally for growth and division. The cycle plays a crucial function in the breakdown of the organic fuel molecules and specifically the glucose, amino acids, and some other essential sugars. Firstly before the more massive particle enters the TCA cycle, they get degraded into two-carbon compound commonly known as the acetyl CoA (Acetyl coenzyme A). Once they are introduced into TA cycle, the acetyl coenzyme is converted into a different form known as the carbon (IV) oxide alongside with energy. (Pieters, J., & McKinney, J. D. 2013). The sequence consists of eight vital steps each composed of several enzymes. Initially, then circle commences when the coenzyme A reacts with an essential compound known as oxaloacetate to produce citrate finally releasing coenzyme A.

Moreover, in a series of reactions, the citrate undergoes some rearrangement forming isocitrate. The isocitrate loses some molecules of carbon (IV) then undergoes oxidation forming a new alpha-ketoglutarate. The newly formed alpha-ketoglutarate loses a carbon (iv) oxide molecule getting oxidized to form succinyl coenzyme A. The next step involves succinyl coenzyme A being enzymatically converted to succinate whereby succinate gets oxidized forming fumarate. New compound fumarate gets hydrated in turn to produce malate, and finally, malate gets oxidized forming oxaloacetate. Every full turn of the cycle leads in the regeneration of oxaloacetate as well as the formation of two molecules of carbon (IV) oxide gas.

The production of useful energy is achieved through distinct steps in the cycle of reactions. In the conversion of coenzyme A to succinate, a single molecule of adenosine triphosphate known for powering molecules is typically produced. Usually, a higher percentage of the energy obtained from the tricarboxylic acid cycle, however, is harnessed by the compounds known as the flavin adenine dinucleotide (FAD) as well as nicotinamide adenine dinucleotide (NAD) is later converted to adenosine triphosphate. The transfer of energy happens through the electron relays from an individual substance to the other in chemical processes known as reduction and oxidation. The reduction processes translate to the addition of electrons to an element while oxidation refers to the significant loss of particles to a given substance. For an individual phase in TAC cycle, typically three molecules of nicotinamide adenine dinucleotide are reduced to NADH at the same time, one molecule of flavin adenine dinucleotide get reduced to FADH2. The given molecules transfer the energy they possess to the transport chain of the electron which is usually a pathway acting as part of the third stage of the cellular respiration. Finally, the electron transport chain releases energy for it to get converted to adenosine triphosphate through oxidative phosphorylation process.

The ICL consist of a mechanism in which there is a regular conversion of isocitrate into succinate and glycosylate. Usually, the first step composes deprotonation of the isocitrate hydroxyl group whereby the fragmentation follows forming succinate and glycosylate. The following three residues have been proposed to be involved in the catalytic phase; histidine and cysteine which are conserved in the KKCGH motif sequence alongside with the unrecognized residues close to the substrate at the active domain. The cysteine residue functions as the acid that aids in the formation of succinate co-product and at the same time the residue of histidine undergoes some interaction with the cysteine thus facilitating the creation of the act-carboxylate. Moreover, the unknown residue functions as a base to the hydroxyl group. (Zheng, H. 2017). The divalent metal ions do a significant role in the catalytic process of both ICL1 and ICL2. The isocitrate substrate cements to the ICL through a process known as chelation of active metal ion site via the carboxylic group as well as the hydroxyl group. Magnesium ions are required for the optimal activities of the catalyst. The replacement of magnesium ions by manganese ions ultimately results in approximately sixty percent loss in the catalytic activities.

The primary function of ICL as depicted in the methylisocitrate and glyoxylate cycles, it is evident that the inhibition target for antimicrobial applications encompassing latent tuberculosis. The main challenges in targeting ACLs are the negligibly small size of the natural substrates, polarity nature of the ICL binding pocket and the need to focus ICL2and ICL1. The polarity of the ICL mandatory pocket suits tiny and polar molecules. The earlier discovery that involved the use of plants and bacterial ICLs has ultimately led to the emergence of compounds that are strictly related to the substrates succinate and glycosylate isocitrate. It composes of 3-bromopyruvate, itaconic acid, and 3-nitropropionate. (Hofer, E. L., & Drexel University. 2012). Itaconic acid alongside with other 3-nitropropionate are noncovalent inhibitors of ICL, but it is believed that 3-bromopyruvate was realized to bind covalently to ICL through the cysteine catalytic residue. Though it has been found that the relevant compounds are almost comparably potent inhibitors against Mycobacterium tuberculosis agent, they are characterized as nonselective as well as containing high levels of toxins thereby rendering them irrelevant as potential drugs. Research shows that some animals which include human beings, as well as mice, have the capability of producing the itaconic acid as a naturally existing antibiotic in macrophages when the body is under infection.

A probable criterion to circumvent the polar site is mainly to aim the interface of oligomerization of ICL1 since monomeric ICL1 was seen to be inactive in the reaction. The best state peptidyl inhibitor was averagely potent in vitro since it validates that the oligomerization boundary might be a probable inhibition aim. (Q, A. A. P. D. 2012). The futuristic peptide-based inhibitor, the research team, is focusing on the improvement of the potency both in vivo stability and at the same time cell permeability of the peptides. The latest efforts to discover new ICL inhibitors have focused on high-throughput screening commonly termed as HTS. The small size of the ICL1 requisite pocket is puzzling for HTS since the figure of composites that can closely fit the binding pocket is known to be limited.

References

Acton, Q. A. (2012). Tuberculosis: Advances in research and treatment.

Committee on Infectious Diseases, & American Academy of Pediatrics,. (2015). Red Book: 2015 report of the Committee on Infectious Diseases.

Duca, G. (2012). Homogeneous catalysis with metal complexes: Fundamentals and applications. Berlin: Springer.

elayati, A. A., & Farnia, P. (2017). Atlas of myobacterium tuberculosis. London: Academic Press.

Gagneux, S. (2017). Strain variation in the mycobacterium tuberculosis complex: Its role in biology, epidemiology and control. Cham: Springer.

Gohlke, H. (2012). Protein-ligand interactions. Weinheim: Wiley-VCH.

Heemskerk, D., Caws, M., Marais, B., Farrar, J., & Springer International Publishing AG. (2015). Tuberculosis in Adults and Children.

Hofer, E. L., & Drexel University. (2012). The Treatment of Latent Tuberculosis Infection in Philadelphia: An Evaluation of Treatment Completion by Drug Regimen Among Pediatric and Adult Patients, 2005-2010.

In Beckler, M. (2015). Encyclopedia of Tuberculosis: Volume I.

In Hatfull, G. F., & In Jacobs, W. R. (2014). Molecular genetics of mycobacteria.

In Schlossberg, D., & American Society for Microbiology. (2011). Tuberculosis and nontuberculous mycobacterial infections. Washington, D.C: ASM Press.

Kuriyan, J., Konforti, B., & Wemmer, D. (2013). The molecules of life: Physical and chemical principles.

LIVESAY, D. E. N. N. I. S. R. (2016). PROTEIN DYNAMICS. Place of publication not identified: HUMANA.

McHugh, T. D. (2013). Tuberculosis: Laboratory diagnosis and treatment strategies. Oxfordshire: CAB International.

Pieters, J., & McKinney, J....